Results 271 to 280 of about 181,215 (307)
Some of the next articles are maybe not open access.

Reperfusion Therapies in Acute Ischemic Stroke

Recent Patents on CNS Drug Discovery, 2015
Acute Ischemic stroke (IS) remains a leading cause of mortality and long-term disability. Owing to the time-constraints, only a fraction of acute IS patients receive the established and approved thrombolytic therapy and a sizeable proportion of acute IS stroke survivors remain permanently disabled.
Leonard L L, Yeo   +4 more
openaire   +2 more sources

Revascularization and reperfusion therapy

2008
This chapter focuses on revascularization and reperfusion therapy in the setting of ACS. Revascularization therapy is distinct from reperfusion therapy. The former takes place in non-ST-elevation or ST-elevation ACS, while reperfusion is employed only for ST-elevation myocardial infarction.
Anthony A Bavry, Deepak L Bhatt
openaire   +1 more source

Reperfusion Therapy for Acute Vertebrobasilar Occlusion

Interventional Neuroradiology, 1997
We reviewed retrospectively our experience in treating 10 patients with acute vertebrobasilar occlusion. Nine patients were treated with interventional reperfusion therapy and the remaining one patient with top of the basilar embolism was treated conservatively because of deep coma and decerebrate rigidity with severely reduced cerebral blood flow ...
H, Ohta   +7 more
openaire   +2 more sources

Therapy for early reperfusion after stroke

Nature Clinical Practice Cardiovascular Medicine, 2006
Ischemic stroke is a leading cause of death and disability in the Western world. At present, intravenous administration of tissue plasminogen activator within 3 h of symptom onset is the only proven effective treatment to re-establish cerebral blood flow in the case of acute vessel occlusion.
Eric, Juttler   +2 more
openaire   +2 more sources

REPERFUSION THERAPY FOR ACUTE MYOCARDIAL INFARCTION

Emergency Medicine Clinics of North America, 2001
A mechanical approach to reperfusion using direct coronary angioplasty is now an established and effective treatment for acute myocardial infarction, but it is not immediately available at most community hospitals. This article will outline the indications for use of reperfusion therapy on patients with AMI, discuss all currently available treatment ...
J A, McPherson, R S, Gibson
openaire   +2 more sources

THERAPY OF REPERFUSION ARRHYTMIAS

Bratislavské lekárske listy, 2004
INTRODUCTION: According to literature, reperfusion arrhytmias that cause hemodynamic instability or subjective discomfort in acute myocardial infarction (AMI) should be treated METHODS AND PATIENTS: Authors investigated the frequency of different types of therapy used in reperfusion arrhytmias (frequent premature ventricular complexes, non-sustained ...
Tomulić, Vjekoslav   +4 more
openaire   +2 more sources

Reperfusion Therapy in Acute Myocardial Infarction

New England Journal of Medicine, 2002
Coronary arterial occlusion due to thrombosis is the cause of most cases of myocardial infarction accompanied by ST-segment elevation.
Richard A, Lange, L David, Hillis
openaire   +2 more sources

Current gaps in acute reperfusion therapies

Current Opinion in Neurology
Purpose of review Advances in intravenous thrombolysis and endovascular thrombectomy have significantly reduced disability and improved outcomes associated with acute ischemic stroke. Recent findings An expansion of indications for reperfusion therapies in select groups of patients ...
Thanh N, Nguyen   +4 more
openaire   +2 more sources

Reperfusion: Pathophysiologie, Prävention, Therapie

1991
Es ist eine Binsenweiheit, das ohne Reperfusion die Wiederherstellung einer gestorten oder transplantierten Organfunktion nicht moglich ist. Es gibt sogar Untersuchungen, wonach die langfristige Restitution eines zerebralen Insultes um so besser ausfallt, je rigoroser initial reperfundiert wurde [9].
openaire   +1 more source

Adjunctive Reperfusion Therapy Post-AMI

2011
• Reperfusion of the occluded coronary artery in an ST-segment-elevation myocardial infarction is the most effective approach for reducing infarct size, preserving left ventricular ejection fraction, lowering the incidence and severity of congestive heart failure and improving prognosis• Hence, several pharmacologic agents intended to improve target ...
Thorsten Reffelmann, Robert Kloner
openaire   +1 more source

Home - About - Disclaimer - Privacy